back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Recent filings | ||||||
| Filed 2026-06-19 11:01 Tx date 2026-06-18 |
$MSCL
Satellos Bioscience Inc. |
Nawacki, Mark Henry
4 - Director of Issuer
Holder: Arlington Capital Holdings Inc. (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
+15,000 vol |
40,000 | |
| Older filings | ||||||
| Filed 2026-04-07 18:34 Tx date 2026-04-07 |
$MSCL
Satellos Bioscience Inc. |
Nawacki, Mark Henry
4 - Director of Issuer
Holder: Arlington Capital Holdings Inc. (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
+4,500 vol |
25,000 | |
| Filed 2026-04-07 18:33 Tx date 2026-04-06 |
$MSCL
Satellos Bioscience Inc. |
Nawacki, Mark Henry
4 - Director of Issuer
Holder: Arlington Capital Holdings Inc. (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
+5,500 vol |
20,500 | |
| Filed 2026-04-07 08:32 Tx date 2026-04-02 |
$MSCL
Satellos Bioscience Inc. |
Gleeson, Francis (Frank) Michael
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$896,197
+108,630 vol $8.25 each |
624,936 | |
| Filed 2026-04-02 20:00 Tx date 2026-04-02 |
$MSCL
Satellos Bioscience Inc. |
Paone, Antoinette
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$221,611
+26,862 vol $8.25 each |
104,156 | |
| Filed 2026-04-02 19:58 Tx date 2026-04-02 |
$MSCL
Satellos Bioscience Inc. |
Farwell, Wildon
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$448,074
+54,312 vol $8.25 each |
208,312 | |
| Filed 2026-04-02 19:56 Tx date 2026-04-02 |
$MSCL
Satellos Bioscience Inc. |
Williams, Elizabeth
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$298,740
+36,211 vol $8.25 each |
208,312 | |
| Filed 2026-04-02 19:53 Tx date 2026-04-02 |
$MSCL
Satellos Bioscience Inc. |
Lambert, Philip David
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$298,740
+36,211 vol $8.25 each |
234,127 | |
| Filed 2026-04-02 19:47 Tx date 2026-04-02 |
$MSCL
Satellos Bioscience Inc. |
Rudnicki, Michael Anthony
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$302,436
+36,659 vol $8.25 each |
260,390 | |
| Filed 2026-03-13 12:58 Tx date 2026-03-12 |
$MSCL
Satellos Bioscience Inc. |
Nawacki, Mark Henry
4 - Director of Issuer
Holder: Arlington Capital Holdings Inc. (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
+15,000 vol |
15,000 | |
| Filed 2026-03-13 12:42 Tx date 2025-11-13 |
$MSCL
Satellos Bioscience Inc. |
Nawacki, Mark Henry
4 - Director of Issuer
Holder: Arlington Capital Holdings Inc. (Indirect Ownership)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2026-02-18 14:21 Tx date 2026-01-30 |
$MSCL
Satellos Bioscience Inc. |
Nawacki, Mark Henry
4 - Director of Issuer
Direct Ownership
|
Options
37 - Stock split or consolidation
|
-202,834 vol |
18,439 | |
| Filed 2026-02-13 22:52 Tx date 2026-01-30 |
$MSCL
Satellos Bioscience Inc. |
Bloom, Brian Matthew
4 - Director of Issuer
Holder: Bloom Burton Development Corporation (Indirect Ownership)
|
Common Shares
37 - Stock split or consolidation
|
-5,520,167 vol |
501,833 | |
| Filed 2026-02-13 22:52 Tx date 2026-01-30 |
$MSCL
Satellos Bioscience Inc. |
Bloom, Brian Matthew
4 - Director of Issuer
Holder: Bloom Burton & Co. Inc. (Indirect Ownership)
|
Common Shares
37 - Stock split or consolidation
|
-5,591,674 vol |
508,334 | |
| Filed 2026-02-13 22:51 Tx date 2026-01-30 |
$MSCL
Satellos Bioscience Inc. |
Bloom, Brian Matthew
4 - Director of Issuer
Holder: 2194655 Ontario Inc. (Indirect Ownership)
|
Common Shares
37 - Stock split or consolidation
|
-616,005 vol |
56,000 | |
| Filed 2026-02-13 22:50 Tx date 2026-01-30 |
$MSCL
Satellos Bioscience Inc. |
Bloom, Brian Matthew
4 - Director of Issuer
Direct Ownership
|
Common Shares
37 - Stock split or consolidation
|
-739,572 vol |
67,233 | |
| Filed 2026-02-13 22:47 Tx date 2026-01-30 |
$MSCL
Satellos Bioscience Inc. |
Bloom, Brian Matthew
4 - Director of Issuer
Direct Ownership
|
Options
37 - Stock split or consolidation
|
-40,059 vol |
3,641 | |
| Filed 2026-02-13 19:25 Tx date 2026-02-06 |
$MSCL
Satellos Bioscience Inc. |
Bloom, Brian Matthew
4 - Director of Issuer
Holder: Bloom Burton Development Corporation (Indirect Ownership)
|
Common Shares
37 - Stock split or consolidation
|
-5,520,167 vol |
501,833 | |
| Filed 2026-02-13 19:25 Tx date 2026-02-06 |
$MSCL
Satellos Bioscience Inc. |
Bloom, Brian Matthew
4 - Director of Issuer
Holder: Bloom Burton Development Corporation (Indirect Ownership)
|
Common Shares
37 - Stock split or consolidation
|
-5,520,167 vol |
||
| Filed 2026-02-13 19:22 Tx date 2026-02-06 |
$MSCL
Satellos Bioscience Inc. |
Bloom, Brian Matthew
4 - Director of Issuer
Holder: Bloom Burton & Co. Inc. (Indirect Ownership)
|
Common Shares
37 - Stock split or consolidation
|
-5,591,674 vol |
508,334 | |